Search

Your search keyword '"de Alava, Enrique"' showing total 135 results

Search Constraints

Start Over You searched for: Author "de Alava, Enrique" Remove constraint Author: "de Alava, Enrique" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
135 results on '"de Alava, Enrique"'

Search Results

1. Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology

3. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)

4. Small round cell sarcomas

5. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

8. Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

9. Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

11. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

17. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1–NFATc2 fusion from Ewing sarcoma

20. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1

22. Contributors

23. EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism

24. Data from A Pivotal Role for Heat Shock Protein 90 in Ewing Sarcoma Resistance to Anti-Insulin-like Growth Factor 1 Receptor Treatment: In vitro and In vivo Study

25. Supplementary Methods, Table 1, Figures 1-8 from A Pivotal Role for Heat Shock Protein 90 in Ewing Sarcoma Resistance to Anti-Insulin-like Growth Factor 1 Receptor Treatment: In vitro and In vivo Study

28. Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma

29. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)

30. Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR)

31. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

33. Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR).

38. A Global CollaboRAtive Study of CIC-Rearranged, BCOR::CCNB3-Rearranged and Other Ultra-Rare Unclassified Undifferentiated Round Cell Sarcomas (GRACefUl)

40. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

41. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

42. Sarcoma classification by DNA methylation profiling

44. Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

45. IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort.

46. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity

49. Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

50. Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)

Catalog

Books, media, physical & digital resources